is mounjaro a semaglutide compound Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), major breakthrough for the treatment of obesity With the high cost of

The only approved oral GLP-1 drug is Rybelsus, a pill for type 2 diabetes from Novo Nordisk, the same company that makes semaglutide and sells it as Ozempic and Wegovy

Retatrutide belongs to a new class of drugs called triple agonists

Based on typical FDA review timelines and the current progress of trials, analysts project: Phase 3 trial completion: Late 2025 to early 2026 FDA submission: First half of 2026 Potential FDA approval: Q3 2026 to Q1 2027 Commercial availability: 2-3 months post-approval The FDA has not granted any special designations (Breakthrough Therapy, Fast Track) for Retatrutides obesity indication, which may mean standard review timelines apply

Packaging can incorporate these elements along with warnings and handling instructions

But because a coach will provide structure, habits, routine, and accountability

Side effects are generally short-term and manageable